Comments
The board of Aurobindo Pharma on Thursday approved fourth interim dividend of ₹4.50 a share (face value: ₹1) for FY22. The company has already fixed June 7 as the record date to identify eligible shareholders to receive the payment of interim dividend. The interim dividend will be paid on or before June 15.
The company had earlier announced ₹1.50 as interim thrice (February 2022, November and August 2021).
Shares of Aurobindo Pharma closed 1.35 per cent higher at ₹529.85 on the BSE.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.